1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Epidemics (including Covid-19, not Long Covid)

Discussion of epidemics including Covid-19

Page 4 of 26
Sort By:
Title Start Date
Replies Views
Last Message ↓
  1. SNT Gatchaman

    A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling, 2023, Hackney et al.

    SNT Gatchaman, Oct 11, 2023
    Replies:
    3
    Views:
    347
    SNT Gatchaman
    Oct 11, 2023
  2. Mij

    Viral kinetics of sequential SARS-CoV-2 infections, 2023, Stephen M. Kissler et al

    Mij, Oct 6, 2023
    Replies:
    0
    Views:
    302
    Mij
    Oct 6, 2023
  3. EndME

    Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19, 2023, Kawakami et al

    EndME, Oct 5, 2023
    Replies:
    0
    Views:
    360
    EndME
    Oct 5, 2023
  4. Mij

    Impact of COVID-19 on Physical Fitness in Central Indian Athletes Aged 20-30 Years: A Cross-Sectional Pilot Study, 2023, Nitin B. Dhokane et al

    Mij, Oct 5, 2023
    Replies:
    0
    Views:
    348
    Mij
    Oct 5, 2023
  5. SNT Gatchaman

    Computer Weekly: Top science journal faced secret attacks from Covid conspiracy theory group

    SNT Gatchaman, Oct 4, 2023
    Replies:
    1
    Views:
    452
    ukxmrv
    Oct 5, 2023
  6. Sly Saint

    Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concern, 2023

    Sly Saint, Oct 4, 2023
    Replies:
    2
    Views:
    370
    Amw66
    Oct 5, 2023
  7. Sly Saint

    Chronic Fatigue and Dis-Autonomy following COVID-19 Vaccination is Distinguished from Normal Vaccination Response by Altered Blood Markers 2023

    Sly Saint, Oct 3, 2023
    Replies:
    1
    Views:
    347
    SNT Gatchaman
    Oct 3, 2023
  8. Mij

    Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications, 2023, Colin R. Dormuth

    Mij, Oct 2, 2023
    Replies:
    0
    Views:
    260
    Mij
    Oct 2, 2023
  9. Mij

    The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs

    Mij, Sep 29, 2023
    Replies:
    0
    Views:
    253
    Mij
    Sep 29, 2023
  10. SNT Gatchaman

    [Preprint] Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10, 2023, Lopez-Ayllon et al.

    SNT Gatchaman, Sep 27, 2023
    Replies:
    0
    Views:
    337
    SNT Gatchaman
    Sep 27, 2023
  11. SNT Gatchaman

    A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes, 2023, Sanderson et al.

    SNT Gatchaman, Sep 27, 2023
    Replies:
    2
    Views:
    326
    Dolphin
    Sep 27, 2023
  12. Andy

    Nature article: COVID vaccines linked to unexpected vaginal bleeding

    Andy, Sep 26, 2023
    Replies:
    2
    Views:
    434
    SNT Gatchaman
    Sep 27, 2023
  13. Sly Saint

    A brief overview of SARS-CoV-2 infection and its management strategies: a recent update 2023, Das et al

    Sly Saint, Sep 25, 2023
    Replies:
    2
    Views:
    279
    rvallee
    Sep 25, 2023
  14. Dakota15

    USA - NIH: Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins, Sept 2023

    Dakota15, Sep 24, 2023
    Replies:
    0
    Views:
    261
    Dakota15
    Sep 24, 2023
  15. Mij

    TMPRSS2 activation of Omicron lineage Spike glycoproteins is regulated by TMPRSS2 cleavage of ACE2, 2023, Anupriya Aggarwal et al

    Mij, Sep 23, 2023
    Replies:
    1
    Views:
    309
    Mij
    Sep 23, 2023
  16. SNT Gatchaman

    [Preprint] Identification of a Druggable Site on GRP78 at the GRP78-SARS-CoV-2 Interface and Compounds to Disrupt that Interface, 2023, Lazou et al.

    SNT Gatchaman, Sep 15, 2023
    Replies:
    0
    Views:
    342
    SNT Gatchaman
    Sep 15, 2023
  17. EndME

    Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19, 2023, Geyer et al

    EndME, Sep 13, 2023
    Replies:
    1
    Views:
    344
    EndME
    Sep 13, 2023
  18. EndME

    Comparison of semen parameters in the same patients before and after diagnosis of COVID-19, 2023, Cakir

    EndME, Sep 12, 2023
    Replies:
    1
    Views:
    295
    rvallee
    Sep 12, 2023
  19. Mij

    Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients

    Mij, Sep 12, 2023
    Replies:
    4
    Views:
    339
    duncan
    Sep 12, 2023
  20. Mij

    Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir, 2023, Yinkai Duan et al

    Mij, Sep 11, 2023
    Replies:
    0
    Views:
    270
    Mij
    Sep 11, 2023
Showing threads 61 to 80 of 506

Thread Display Options

Loading...
Page 4 of 26